Article: PROTEIN STRUCTURE MAY LEAD TO TREATMENT FOR INFECTION TARGETING CYSTIC FIBROSIS PATIENTS

The U.S. Department of Energy's Argonne National Laboratory issued the following press release:

Researchers at the U.S. Department of Energy's Argonne National Laboratory have determined the structure of a key protein believed to play a role in a deadly infection that afflicts the lungs of cystic fibrosis patients. This finding, published in today's issue of Science, may lead to a new drug to treat the bacterial infection.

Pseudomonas aeruginosa, a pathogen that infects more than 80 percent of cystic fibrosis patients, is a leading cause of these patients' deaths. P. aeruginosa is difficult to treat because it is resistant to many drugs.

While working through a number of pathogenic ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!